Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: A Trial of Lu AG13909 in Adult Participants With Cushing's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Lu AG13909 in adults with Cushing's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lu AG13909

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Cushing's Disease | Phase 2 | Status: RECRUITING